Skip to content

Capacitive-Resistive Energy Transfer (CRET) for the Treatment of Low Back Pain

CRET Therapy in Low Back Pain Treatment.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06728215
Enrollment
52
Registered
2024-12-11
Start date
2023-10-01
Completion date
2024-06-01
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

This retrospective observational study compares the effectiveness of two CRET therapies in adults with physical dysfunction. It evaluates whether the UNIQ electrode Fisiowarm 7.0 improves lumbar ROM (Schober test) and reduces pain (VAS scores) more effectively than the classical methodology, with assessments at baseline (T0) and two weeks (T1).

Detailed description

The goal of this retrospective observational study is to compare the effectiveness of two CRET therapy methodologies in adults (mean age ±SD: 51.23±16.89 for treated, 51.20±14.34 for control; M/F ratio: 42%M, 58%F for treated, 40%M, 60%F for control) experiencing physical dysfunction. The main questions it aims to answer are: * Does treatment with the UNIQ electrode Fisiowarm 7.0 improve range of motion (ROM) as measured by the Schober test more effectively than the classical methodology? * Does treatment with the UNIQ electrode Fisiowarm 7.0 reduce pain levels, as reported through VAS scores, more effectively than the classical methodology? Participants underwent therapy with either Fisiowarm 7.0 or Activ CT8 INDIBA® as per their group assignment. Have their ROM measured using the Schober test at baseline (T0) and after two weeks (T1). Report VAS scores before therapy (T0) and after two weeks (T1) to assess pain levels.

Interventions

DEVICECRET 1

Fisiowarm 7.0 and the new capacitive/resistive electrode, for 15' at a frequency of 300 KHz (Treated Group).

DEVICECRET 2

Classical methodology using the monopolar electrode Activ CT8 INDIBA® at a frequency of 448 KHz in both resistive and capacitive modes, for 10 min each mode with two different electrodes. (Control group).

Sponsors

D&V FARMA srl
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 years old or older * reported a visual analogic scale (VAS) for pain equal or greater than 6 cm * a ROM measured by Schober test * naïve to CRET therapy * non-concomitant physiotherapy treatment (e.g. diathermy, laser therapy etc..).

Design outcomes

Primary

MeasureTime frameDescription
VAS2 WEEKSThe Visual Analog Scale (VAS) measures pain intensity on a scale of 1 to 10, where 1 represents no pain and 10 represents worst imaginable pain.

Secondary

MeasureTime frameDescription
ROM2 WEEKSThe Schober test measures the range of motion (ROM) in the lumbar spine during forward bending, with a normal increase of 4-7 cm indicating good flexibility. An increase of less than 4 cm suggests restricted lumbar mobility, often associated with spinal disorders.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026